
I didn't re-buy the stock back, because I was traveling, and I had just sold it. It's now trading up to a bit over 12.
This morning, they signed a deal with three partners outside the US with moksha8 Pharmaceuticals for Brazil and Mexico, N T Pharma Group for China, and Neopharm Group for Israel.
Studies have shown that on IV treatment of Peramivir works as well as five days of Tamiflu pills.
And that means, this number still has legs, because this will be the new "flu stock."
It already has FDA fast track approval, so the street will run with it.
10 comments:
Where do you see this running to short term?
No one believe this news is "tangible" Adam Feurstein had this negative spin on the news
"But there's little news here. It's been well known for months that U.S. officials were weighing a peramivir purchase. In fact, a lot of bullish Biocryst investors expected a deal to be completed before the summer ended. In other words, no stockpiling contracts to date and Biocryst isn't making any money from peramivir or its partners yet. "
I think he's wrong. Tamiflu had over $900 million in sales for Roche in H1, and now they are going to expand production. So now you are looking at close to $2 billion of annual sales, as Governments increase the stockpile the drug.
It's a big market, and I think those short this name are wrong with their ho hum spin.
The market is making new highs... What happened to the upcoming crash that was advertised?? :D
The market is making new highs... What happened to the upcoming crash that was advertised?? :D
It sure wasn't advertised here!!
GS upgraded BIDU today. I guess the BIDU huddle was last week to their favorite clients.
See Cramer's tout on AAPL? No huddle needed here!
seems like they were beating it down all day after the spike...picked up a small amount to see...looking for $2 pop...you think it will go to 14?
Yes i think so
Still no love today for bcrx..what gives?
Post a Comment